Welcome to Senior Cannabis Digest. This week we look at cannabis and safe driving, holiday gift ideas, index funds that have added a cannabis company and more. Enjoy.
Notable Numbers
Top takeaway: If you consume cannabis, always wait several hours before you drive.
This week’s notable number is four, as in four hours. According to a new post from the Colorado Department of Transportation (CDOT), developed with the assistance of the Colorado Department of Public Health and Environment (CDPHE), that’s how long your driving may be impaired if you smoke, dab or vape cannabis.
The CDOT post offers guidance on other methods of cannabis consumption as well. For example, an edible can impair a driver for at least eight hours and drinking THC or using a tincture can impair a person for up to six hours.

CDOT and CDPHE also advise that using cannabis and alcohol together – what’s known as poly-impaired driving – can enhance the effects of each substance and cause increased side effects. That’s why, if you have consumed alcohol in addition to cannabis, they contend it’s crucial to wait even longer than four hours before getting behind the wheel.
The bottom line, according to CDOT, is if you’re going to consume cannabis, always wait before you drive, even if that wait may be several hours in length. The Department emphasizes that driving impaired should never be an option.
While the CDOT post doesn’t mention turkey, tryptophan or pumpkin pie, we suspect that the entire menu of holiday treats can also contribute to impairment. Sometimes waiting – and napping if necessary – can be the holiday gift your family and other drivers need.
To learn more, we urge you to read the post from the Colorado Department of Transportation (CDOT). Simply click on the link that follows.
Holiday Gift Ideas
Top takeaway: There are holiday gifts for mature cannabis consumers that are functional and stylish.
If you have a mature consumer on your holiday gift list but don’t know what to do, don’t fret. A company called NWTN Home has what’s described as a collection of chic smoking essentials that are designed to offer “a more elevated way to enjoy cannabis at home.”
So says Aazim Jafarey in an article he penned for The Daily Beast. He believes NWTN’s 420-friendly products can also double as elegant and functional houseware items. Here are three of his tips.
First up is the Symi Ash Tray. Said to blend vintage-inspired design with modern materials, it features a terrazzo base made from recycled glass, a removable borosilicate glass top, grooves to keep essentials in place and added silicone footing for shock-absorption It retails for $48.

Next, there’s a luxury grinder that would be a stylish addition to any bar cart. Designed with a toothless grinding system and magnetic closure, the elegant accessory ensures an even grind every time. Priced at $52, the Mortar and Pestle Grinder features a design inspired by the enduring simplicity of traditional kitchen tools.
His third gift idea is NWTN’s Deco Bubbler smoking device. Described as a striking fusion of vintage design and modern function, the bubbler is said to be modeled after Art Deco glassware. Crafted with two easy-to-clean components, the Deco Bubbler will set you back $54, but hey, it’s the holidays.
For more ideas, we urge you to read Aazim Jafarey’s holiday gift guide in the November 10, 2026 issue of The Daily Beast.com.
www.thedailybeast.com/cheat-sheet#nwtn-homes-elegant-and-functional-cannabis-accessories
Investor News and Notes
Top takeaway: One of the country’s largest multi-state cannabis operators has been added to two index funds.
In a move that probably would not have been possible prior to the rescheduling of cannabis, Trulieve, one of the country’s largest multi-state cannabis operators has announced it’s set to join the Russell 2000 and 3000 Indices as part of the funds’ semi-annual reconstitution.
Joining the Russell indices follows the company’s decision earlier this year to put its subordinate voting shares up for sale on the New York Stock Exchange (NYSE).
Subordinate voting shares are a class of stock that carry voting rights, but possess fewer votes per share compared to other types of shares. Typically, they let public investors buy into a company’s financial growth while allowing founders to keep majority voting through “super-voting” shares that can often carry 10 or more votes per share.

Said Trulieve CEO Kim Rivers, “We are thrilled to join the Russell 2000 and 3000 Indices, following uplisting to the New York Stock Exchange and domestication to the United States. This marks another major milestone for Trulieve, building on our inclusion in the S&P Total Market, S&P Completion, and Morningstar Total Stock Market indices earlier this year. Index inclusion raises awareness of Trulieve, ultimately leading to greater liquidity and access to institutional investors.”
According to an article that appeared in the publication Cannabis Equipment News, joining these index funds is the latest move by Trulieve to raise its public profile following medical marijuana rescheduling earlier this year. The company also recently completed a corporate restructuring and investment by a third party resulting in the deconsolidation of operations in markets serving both medical and adult use customers. Trulieve’s remaining consolidated operations consist only of state licensed medical marijuana facilities and include 206 medical marijuana dispensaries supported by 3.5 million square feet of production capacity registered with the DEA.
Cannabis – it’s what’s for business.
To learn more, we suggest reading the article that appeared in the November 16, 2026 issue of Cannabis Equipment News.com.
The Shape of Things to Come
Top takeaway:The largest pharmacy chain in the UK is implementing a new way to qualify for medical cannabis.
In a move that’s said to be a first for a British “high street” pharmacy chain, a pharmacy called Boots will begin prescribing medical cannabis online.
In the UK, the term high street pharmacy refers to a walk-in retail and healthcare shop that prescribes medicines and provides in-person healthcare services for both the National Health Service (NHS) and private care patients.

According to an article by Kevin Rawlinson that appeared in The Guardian, Boots will offer an online assessment and enrollment service to patients aged 25 and older who have medical conditions that make them eligible to receive and use medical cannabis products, such as chronic pain, anxiety or insomnia.
Called Sure Leaf, the service will be part of a collaborative research program with the University of Nottingham that will examine patient outcomes, prescribing practices and experience in the treatment of chronic pain.
Rawlinson notes that potential patients will be invited to start their assessment online. Their suitability for the program will then be reviewed by a clinical team, before they are invited to a video consultation with a consultant.
According to Boots, any prescription would be “independently reviewed by a multidisciplinary clinical team that includes a second, independent consultant, before treatment begins.” It also said any patient wishing to be prescribed medical cannabis must first have tried conventional treatments without success.
Said Jamie Kerruish, Boots’ chief healthcare officer, “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief. This (program) can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy.”
He added, “Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.”
Dr David Gwynne, the medical director of the pharmacy’s online service, said, “Our priority is to ensure patients receive responsible, clinically led care, from their initial specialist assessment through to ongoing monitoring and review once treatment begins.”
You can learn much more by reading Kevin Rawlinson’s article in the November 16, 2026 issue of The Guardian.com.
www.theguardian.com/business/2026/nov/16/boots-pharmacy-begin-prescribing-medical-cannabis-uk
Have a great Thanksgiving. See you after the holiday.

Senior Cannabis Digest is compiled and edited by Joe Kohut and John Kohut. You can reach them at joe.kohut@gmail.com and at 347-528-8753.